Clinical Trial Update: Intestinal Microbiome Post-Azythromycin/Albendazole Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating intestinal microbiome changes after azithromycin/albendazole treatment for helminth infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helminth Infection

Drugs mentioned

• Azithromycin/Albendazole

Snippet

Sponsor: University of California, San Francisco | Conditions: Helminth Infection | Phase 4 | Status: WITHDRAWN